首页> Cancer: A Journal of the American Cancer Society> Low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study

Low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study

导出原文传递

翻译打印收藏纠错

关键词 chronic myeloid leukemia TKI de-escalation treatment discontinuation treatment-free remission tyrosine kinase inhibitors

发布时间 2020-09-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer

2020年126卷15期

3438-3447页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Cancer

2020年126卷15期

3438-3447页

检索历史清除

Low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study

Cancer

相似文献

同项目论文

Cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study

Cancer

相似文献

同项目论文

Cancer

相关期刊

检索历史清除